S-1/A: ClearSign Technologies Files Amendment to S-1 Registration for Resale of Common Stock and Warrants

ClearSign Technologies has filed an amendment to its S-1 registration statement to register the resale of common stock and warrants by selling stockholders.

Summary

• ClearSign Technologies has filed an amendment to its Form S-1 registration statement with the SEC.
• The registration covers the resale of up to 5,599,763 shares of common stock, 4,498,642 shares issuable upon exercise of pre-funded warrants, 15,147,606 shares issuable upon exercise of private warrants, and 15,147,606 private warrants.
• These securities were issued in connection with a private placement and the exercise of a participation right.
• The selling stockholders may sell these securities from time to time on any stock exchange or in private transactions.
• ClearSign will not receive any proceeds from the resale of these securities, but will receive proceeds from any cash exercise of the warrants.
• The company's common stock is listed on the Nasdaq Capital Market under the symbol CLIR, and the last reported sale price on July 2, 2024, was $0.86.
• The document also references a Nasdaq deficiency notice due to the company's failure to maintain a minimum bid price of $1 per share, with a deadline of October 29, 2024, to regain compliance.
• The company recently completed a public offering and concurrent private placement, generating gross proceeds of approximately $9.3 million and $0.6 million respectively.
• The company's certificate of incorporation was amended to increase the number of authorized shares of common stock to 87,500,000.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While the company has successfully raised capital through recent offerings, it faces challenges such as Nasdaq compliance issues and a history of losses. The reliance on future warrant exercises for funding adds uncertainty.

Positives

• The completion of a public offering and concurrent private placement on April 23, 2024, resulted in combined gross proceeds of approximately $9.3 million, and net proceeds of approximately $8.1 million.
• The exercise of Public Ventures' option to purchase additional shares of common stock and Public Warrants resulted in additional gross proceeds of approximately $0.6 million, and net proceeds of approximately $0.6 million after deducting $0.05 million in underwriter commissions.
• The company's certificate of incorporation was amended to increase the number of authorized shares of common stock to 87,500,000, providing flexibility for future capital raising or other corporate purposes.

Negatives

• ClearSign received a Nasdaq deficiency notice on May 2, 2024, because it did not comply with the minimum $1.00 per share bid price requirement for continued listing.
• The company has until October 29, 2024, to regain compliance with the Nasdaq listing rules, and failure to do so could result in delisting.
• The company will not receive any proceeds from the resale of shares by the selling stockholders, but will only receive proceeds from the cash exercise of warrants.
• The company has a history of losses and expects to continue to experience operating losses and negative cash flows in the near future.

Risks

• The selling stockholders may sell significant amounts of common stock, which could cause the common stock price to decline.
• The company will have broad discretion as to the proceeds that it receives from the cash exercise by any holder of the Warrants, and it may not use the proceeds effectively.
• Investors may experience future dilution as a result of the issuance of the Warrant Shares, future equity offerings, and other issuances of common stock or other securities.
• The price of the company's common stock may be volatile, and the market price of the common stock may decrease.
• If the company fails to comply with Nasdaq's continued minimum closing bid requirements by October 29, 2024, its common stock may be delisted.

Future Outlook

The company intends to use the net proceeds from any cash exercise of the Warrants for working capital, research and development, marketing and sales, and general corporate purposes.

Industry Context

The document highlights ClearSign's focus on the combustion and emissions control systems markets, which are driven by increasing regulatory stringency and the need for energy efficiency. The company believes its ClearSign Core technology offers a cost-effective solution for meeting emissions standards compared to competing products. The document also mentions the growing interest in burner technology that can use hydrogen as a fuel source, which aligns with the current environmental impetus to reduce CO2 emissions.

Comparison to Industry Standards

• The document mentions that ClearSign's technology aims to be more effective and cost-efficient than current industry-standard air pollution control technologies like selective catalytic reduction devices (SCRs) and lowand ultra-low NOx burners.
• The company claims that its technology can reduce nitrogen oxide (NOx) emissions down to the levels required by new stringent emission regulations.
• The document also suggests that burners utilizing ClearSign Core technology can provide increased heat transfer efficiency compared to other emission-reducing technologies, potentially resulting in cost savings in the low to mid-single digit percentage range.

Corporate Governance

Stakeholder Impact

• Shareholders may experience dilution due to the potential exercise of warrants and future equity offerings.
• The company's ability to continue as a going concern is dependent on its ability to generate revenue and obtain additional financing.
• Employees' stock options and restricted stock units may be affected by the company's stock price and financial performance.

Next Steps

• ClearSign must regain compliance with Nasdaq's minimum bid price requirement by October 29, 2024.
• The selling stockholders may offer and sell the registered securities from time to time.
• The company will monitor its common stock's closing bid price and consider available options in the event that its common stock's closing bid price remains below $1 per share.

Key Dates

Keywords

ClearSign Technologies, registration statement, common stock, warrants, resale, private placement, public offering, Nasdaq, deficiency notice, selling stockholders